News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
A new report from Graphite Digital has revealed that 36% of senior leaders in pharma agree that funding is the biggest barrier to digital adoption and transformation, despite increasing spend.
AstraZeneca’s Fasenra (benralizumab) has recently been approved by the FDA for treating severe asthma in children aged 6 to 11 with the eosinophilic phenotype.
Life science startup Limula has raised $6.8 million to take its solution for automating cell therapy manufacturing to the next stage of development.